Valorisations sectorielles Larimar Therapeutics, Inc.
Actions
LRMR
US5171251003
Recherche biotechnologique et médicale
|
Temps réel estimé
Cboe BZX
18:48:45 18/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 3,795 USD | -0,13% |
|
-3,57% | -0,79% |
| 05/08 | Larimar Therapeutics, Inc. : Wedbush optimiste sur le dossier | ZM |
| 04/08 | Larimar Therapeutics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026 | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (Y) | Price to Book (Y) | PEG (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Rendement du dividende (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
 | -2.86x | 2.67x | 0.07x | - | -2.17x | -2.11x | -.--% | 397 M | |
| 20.84x | 4.92x | 1.26x | 7.34x | 14.75x | 16.41x | 1,42% | 70,89 Md | |
| 32.38x | 6.39x | 0.57x | 9.35x | 45.22x | 29.69x | 0,04% | 62,32 Md | |
| -75.68x | 37.98x | 1.02x | 14.64x | -70.6x | -84.56x | -.--% | 27,07 Md | |
| -15.08x | 1.23x | -0.71x | 5.66x | -7.11x | -5.61x | -.--% | 24,78 Md | |
| 28.05x | 3.34x | -1.59x | 5.3x | 17.61x | 19.74x | -.--% | 20,59 Md | |
| 45.07x | 11.22x | 0.39x | 16.55x | 33.56x | 36.25x | 0,33% | 15,52 Md | |
| 18.07x | 5.57x | 1.1x | 5.39x | 12.58x | 13.33x | -.--% | 14,49 Md | |
| -15.33x | 52.46x | 0.82x | 3461.53x | -17.7x | -15.2x | -.--% | 14,14 Md | |
| -84.63x | 27.5x | 1.66x | 7.75x | -64.15x | -62.79x | -.--% | 12,35 Md | |
| -11.42x | -73.29x | 1.79x | 57.14x | -11.92x | -11.7x | -.--% | 9,72 Md | |
| -18.61x | 24.57x | -0x | 18.94x | -20.6x | -18.3x | -.--% | 9,57 Md | |
| -7.21x | - | -0.15x | - | -7.46x | -6.9x | -.--% | 8,98 Md | |
| -8.81x | - | -0.06x | - | - | - | - | 8,97 Md | |
| -31.67x | 8.32x | -0.66x | - | -27.9x | -28.8x | -.--% | 8,17 Md | |
| -56.78x | 9.9x | -1.9x | - | -46.32x | -43.14x | - | 6,86 Md | |
| 15.38x | - | 0.49x | - | - | - | - | 6,6 Md | |
| 54.71x | 1.65x | 0.37x | 3.7x | 16.94x | 33.73x | 0,15% | 6,43 Md | |
| -39.9x | 6.86x | -1.23x | - | -28.73x | -28.89x | -.--% | 6,47 Md | |
| -14.97x | 22.48x | 32.76x | 850.21x | -13.17x | -12.96x | -.--% | 5,97 Md | |
| Moyenne | -8,42x | 9,04x | 1,80x | 343,35x | -9,84x | -9,54x | 0,11% | 17,02 Md | |
| Moyenne pondérée par Capi. | 1,10x | 9,69x | 1,02x | 193,80x | 2,21x | -0,53x | 0,34% |
- Bourse
- Actions
- Action LRMR
- Secteur Larimar Therapeutics, Inc.
- Valorisations sectorielles
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
